Bruce Edward Hansen
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Senators push for AI disclosure rules affecting LPSN. US senators are moving to force AI companies to disclose more information, a development that could impact LivePerson's regulatory environment. As an AI-focused company, LPSN may face new compliance requirements under such legislation. The stock is currently trading well below its 52-week high, with analysts setting a moderate price target.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Mitek Systems noted in RegTech news, releases Q3 2026 earnings. Mitek Systems was mentioned as one of three RegTech companies gaining attention after Bank of America faced a $1.2 billion penalty, highlighting possible increased demand for compliance technology. The company also held its Q3 2026 earnings call, providing updates on recent performance and outlook. These developments keep the stock in focus as investors assess the impact of regulatory trends and the latest results.
Transaction History
| VRSK | ▲ Buy | Option Exercise | 2,336 | $189K | 6/1/2026 | View on chart |
| VRSK | ▼ Sell | Open Market | 2,336 | $409K | 6/1/2026 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 2,335 | $189K | 5/22/2026 | View on chart |
| VRSK | ▼ Sell | Open Market | 2,335 | $400K | 5/22/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 1,347 | $0 | 5/19/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 735 | $0 | 5/20/2025 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 1,179 | $86K | 4/7/2025 | View on chart |
| VRSK | ▼ Sell | Open Market | 1,179 | $337K | 4/7/2025 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 1,179 | $86K | 3/7/2025 | View on chart |
| VRSK | ▼ Sell | Open Market | 1,179 | $348K | 3/7/2025 | View on chart |
| VRSK | ▼ Sell | Open Market | 1,179 | $348K | 2/7/2025 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 1,179 | $86K | 2/7/2025 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 1,179 | $86K | 1/7/2025 | View on chart |
| VRSK | ▼ Sell | Open Market | 1,179 | $322K | 1/7/2025 | View on chart |
| LPSN | ▲ Buy | Grant | 80,000 | $0 | 12/16/2024 | View on chart |
| LPSN | ▼ Sell | Open Market | 84,944 | $72K | 12/11/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 847 | $0 | 5/15/2024 | View on chart |
| LPSN | ▲ Buy | Grant | 59,881 | $0 | 10/5/2023 | View on chart |
| VRSK | ▼ Sell | Open Market | 1,131 | $245K | 5/25/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 958 | $0 | 5/17/2023 | View on chart |
| LPSN | ▲ Buy | Grant | 25,063 | $0 | 4/10/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 792 | $0 | 7/1/2022 | View on chart |
| MITK | ▲ Buy | Grant | 10,068 | $0 | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Verisk price targets trimmed as analysts weigh AI impact
BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.
Verisk price targets trimmed as analysts weigh AI impact. BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.